Key result
Direct oral anticoagulants are as effective and safe as vitamin K antagonists for preventing thromboembolic complications in patients with atrial fibrillation undergoing cardioversion or catheter ablation.
Why the study?
To review the relevance of sinus rhythm control, guideline recommendations, and clinical trial evidence on direct oral anticoagulants for preventing thromboembolic complications in atrial fibrillation.
Do direct oral anticoagulants prevent thromboembolic complications in patients with atrial fibrillation undergoing cardioversion or catheter ablation?
Do direct oral anticoagulants prevent thromboembolic complications in patients with atrial fibrillation undergoing cardioversion or catheter ablation?
Answers are grounded in this paper and cite their sources.
This review confirms that DOACs are an effective and safe alternative to VKAs for stroke prevention in AF patients undergoing cardioversion or catheter ablation, aligning with current guidelines.
This review focuses on the relevance of sinus rhythm control in patients with atrial fibrillation in real-life clinical practice and specific clinical features of patients with this arrhythmia. The authors presented current guidelines on prevention of thromboembolic complications and a review of results from major clinical studies of direct oral anticoagulants. The search for literature and selection of clinical studies for 2009-2020 were performed on websites of the European and Russian Societies of Cardiology, the All-Russian Scientific Society of Arrhythmologists, and in online databases PubMed, EMBASE, eLibrary, and Google Scholar using the key words atrial fibrillation, anticoagulants, ablation, cardioversion, and efficacy and safety.
No takes yet. Share an insight, caveat, or question.
В. А. Ионин (2020) conducted a review in Atrial fibrillation. Direct oral anticoagulants (DOACs) vs. Vitamin K antagonists (VKAs) was evaluated. Direct oral anticoagulants are as effective and safe as vitamin K antagonists for preventing thromboembolic complications in patients with atrial fibrillation undergoing cardioversion or catheter ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: